The journal of allergy and clinical immunology. In practice
-
J Allergy Clin Immunol Pract · Jan 2014
Multicenter StudyOral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions.
Peanut allergy creates the risk of life-threatening anaphylaxis that can disrupt psychosocial development and family life. The avoidance management strategy often fails to prevent anaphylaxis and may contribute to social dysfunction. Peanut oral immunotherapy may address these problems, but there are safety concerns regarding implementation in clinical practice. ⋯ Peanut oral immunotherapy carries a risk of systemic reactions. In the context of oral immunotherapy, those reactions were recognized and treated promptly. Peanut oral immunotherapy may be a suitable therapy for patients managed by qualified allergists/immunologists.